Trial Profile
Neridronic acid in women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Feb 2012
Price :
$35
*
At a glance
- Drugs Neridronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Mar 2012 Results published in Bone.
- 05 Nov 2010 New trial record.